Potential biochemical therapy of glioma cancer

Biochemical and Biophysical Research Communications

Volumn 362, Issue 2, 2007, Pages 225-229

  Yin, Li Tian ^a   Fu, Yue Jun ^a   Xu, Qiao Ling ^b   Yang, Jun ^b   Liu, Zeng Li ^b   Liang, Ai Hua ^a   Fan, Xiao Jun ^a   Xu, Cheng Gang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Chloride channels; Chlorotoxin; Glioma; Potassium channels; Temozolomide

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CHLORIDE CHANNEL; LOMUSTINE; METHOTREXATE; TEMOZOLOMIDE; VOLTAGE GATED POTASSIUM CHANNEL;

ANTINEOPLASTIC ACTIVITY; CELL MIGRATION; DRUG DESIGN; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; MEDULLOBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT SURVEY;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; DACARBAZINE; GLIOMA; HUMANS; INDOLES; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED;

EID: 34548261325     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.167     Document Type: Short Survey

References (34)

1. Sontheimer H. Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci. 26 (2003) 543-549
2. Laws Jr. E.R., and Thapar K. Brain tumors. C.A Cancer J. Clin. 43 (1993) 263-271
3. Wang W.X., and Ji Y.H. Scorpion venom induces glioma cell apoptosis in vitro and inhibits glioma tumor growth in vivo. J. Neurooncol. 73 (2005) 1-7
4. Demuth T., and Berens M.E. Molecular mechanisms of glioma cell migration and invasion. J. Neurooncol. 70 (2004) 217-228
5. DeAngelis L.M. Chemotherapy for brain tumors-a new beginning. N. Engl. J. Med. 352 (2005) 1036-1038
6. Stupp R., Mason W.P., van den Brent M.J., Weller M., Fisher B., Taphoorn M.J., and Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma. N. Engl. J. Med. 352 (2005) 987-996
7. Hegi M.E., Diserens A.C., Gorlia T., Hamou M.F., de Tribolet N., Weller M., and Stupp R. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352 (2005) 997-1003
8. Rutkowski S., Bode U., Deinlein F., Ottensmeier H., Warmuth-Metz M., Soerensen N., and Kuehl J. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N. Engl. J. Med. 352 (2005) 978-986
9. PreuBat K., Beetz C., Michael S., Kraft R., Wolfl S., Kalff R., and Patt S. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci. Lett. 346 (2003) 33-36
10. Kraft R., Krause P., Jung S., Basrai D., Liebmann L., Bolz J., and Patt S. BK channel openers inhibit migration of human glioma cells. Pflugers Arch. 446 (2003) 248-255
11. Ransom C.B., and Sontheimer H. BK channels in human glioma cells. J. Neurophysiol. 85 (2001) 790-803
12. Ransom C.B., O'Neal J.T., and Sontheimer H. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J. Neurosci. 21 (2001) 7674-7683
13. Soroceanu L., Gillespie Y., Khazaeli M.B., and Sontheimer H. Use of chlorotoxin for targeting of primary brain tumors. Cancer Res. 58 (1998) 4871-4879
14. Ullrich N., and Sontheimer H. Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am. J. Physiol. 270 (1996) 1511-1521
15. Olsen M.L., Schade S., Lyons S.A., Amaral M.D., and Sontheimer H. Expression of voltage-gated chloride channels in human glioma cells. J. Neurosci. 23 (2003) 5572-5582
16. Xu H.Y., Liao W.W., and Liu Z.L. Synthesis of the antitumour drug temozolide. Fine Chemical Intermediates 34 (2004) 27-28
17. Agarwala S.S., and Kirkwood J.M. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist 5 (2000) 144-151
18. Athanassiou H., Synodinou M., Maragoudakis E., Paraskevaidis M., Verigos C., Misailidou D., Antonadou D., Saris G., Beroukas K., and Karageorgis P. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J. Clin. Oncol. 23 (2005) 2372-2377
19. Herrlinger U., Rieger J., Koch D., Loeser S., Blaschke B., Kortann R.D., Steinbach J.P., Hundsberger T., Wick W., Meyermann R., Tan T.C., Sommer C., Bamberg M., Reifenberger G., and Weller M. Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. J. Clin. Oncol. 24 (2006) 4412-4417
20. Bringmann A., Francke M., Pannicke T., Biedermann B., Kodal H., Faude F., Reichelt W., and Reichenbach A. Role of glial K(+) channels in ontogeny and gliosis: a hypothesis based upon studies on Muller cells. Glia 29 (2000) 35-44
21. + ion channel blockers. J. Neurosci. 19 (1999) 5942-5954
22. Toro L., Wallner M., Meera P., and Tanaka Y. Maxi-KCa, a unique member of the voltage-gated K channel superfamily. News Physiol. Sci. 13 (1998) 112-117
23. 2+ fluctuations modulate the rate of neuronal migration. Neuron 17 (1996) 275-285
24. Strong P.N., Clark G.S., Armugam A., De-Allie F.A., Joseph J.S., Yemul V., Deshpande J.M., Kamat R., Gadre S.V., Gopalakrishnakone P., Kini R.M., Owen D.G., and Jeyaseelan K. Tamulustoxin: a novel potassium channel blocker from the venom of the Indian red scorpion Mesobuthus tamulus. Arch. Biochem. Biophys. 385 (2001) 138-144
25. Attali B., Wang N., Kolot A., Sobko A., Cherepanov V., and Soliven B. Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J. Neurosci. 17 (1997) 8234-8245
26. Chittajallu R., Chen Y., Wang H., Yan X., Ghiani C.A., Heckman T., McBain C.J., and Gallo V. Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle. Proc. Natl. Acad. Sci. USA 99 (2002) 2350-2355
27. Lyons S.A., O'Neal J., and Sontheimer H. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 39 (2002) 162-173
28. Deshane J., Garner C.C., and Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J. Biol. Chem. 278 (2003) 4135-4144
29. Shen S., Khazaeli M.B., Gillespie G.Y., and Alyarez V.L. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice. J. Neurooncol. 71 (2005) 113-119
30. Mamelak A.N., Rosenfeld S., Bucholz R., and Raubitschek A. Phase I single-does study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J. Clin. Oncol. 24 (2006) 3644-3650
31. Ullrich N., Bordey A., Gillespie G.Y., and Sontheimer H. Expression of voltage-activated chloride currents in acute slices of human gliomas. Neuroscience 83 (1998) 1161-1173
32. McDermott M.W., Sneed P.K., and Gutin P.H. Interstitial brach therapy for malignant brain tumors. Semin. Surg. Oncol. 14 (1998) 79-87
33. Vitaz T.W., Warnke P.C., Tabar V., and Gutin P.H. Brach therapy for brain tumors. J. Neurooncol. 73 (2005) 71-86
34. Newlands E.S., Stevens M.F.G., Wedge S.R., Wheelhouse R.T., and Brock C. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat. Rev. 23 (1997) 35-61